{"product_id":"totallyplc-five-forces-analysis","title":"Totally Porter's Five Forces Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDon't Miss the Bigger Picture\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eTotally’s snapshot reveals initial pressure points—supplier leverage, buyer sensitivity, and newcomer risks—that shape competitive intensity and margins.\u003c\/p\u003e\n\u003cp\u003eThis brief just scratches the surface; unlock the full Porter's Five Forces Analysis to see force-by-force ratings, visuals, and actionable implications tailored to Totally for smarter strategy and investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003euppliers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eClinical Labor Scarcity\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe UK faces a chronic shortfall of clinical staff—NHS vacancies hit 133,000 in Sept 2025—giving doctors and nurses leverage over providers; Totally plc must compete with the NHS and private firms for this scarce pool. \u003c\/p\u003e\n\u003cp\u003eScarcity pushes up pay: agency nursing rates rose ~35% between 2021–2024 and median locum doctor day rates reached ~£650 in 2024, forcing higher operating costs for Totally. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSpecialized Medical Equipment\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe company depends on a handful of global makers for high-end diagnostic and elective-care gear; the top three suppliers control about 68% of the market for MRI\/robotic systems (2024), giving them pricing and delivery leverage. Their proprietary tech and multi-year maintenance contracts (avg. 7–10 years, often with 15–20% annual escalation clauses) are hard to exit, raising switching costs. A 2023 supply shock showed 12–18% service delays, directly cutting specialized service capacity and revenue.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePharmaceutical Pricing\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eAs an urgent and elective care provider, Totally faces supplier price power from major pharmaceutical wholesalers that set list prices and volume discounts; in 2024 UK drug wholesale margins averaged 6–8% while list price inflation ran about 4.5% year-on-year, raising consumable costs.\u003c\/p\u003e\n\u003cp\u003eAlthough the NHS negotiates national rates—saving roughly £1.2bn via single-source deals in 2023—private providers like Totally absorb fluctuating meds costs, since NHS contract prices often stay fixed for 12–24 months.\u003c\/p\u003e\n\u003cp\u003eThat mismatch can compress margins: a 5% rise in drug costs could cut operating margin by ~1.5 percentage points on a typical private clinic with 30% gross margin, so supplier pricing power materially threatens profitability.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital Infrastructure Partners\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eThe shift to integrated care makes third-party digital infrastructure partners critical; global health IT spending hit an estimated $250B in 2024, concentrating power with firms that host EHRs and data platforms.\u003c\/p\u003e\n\u003cp\u003eHigh migration complexity and switching costs—often $5M–$50M per large hospital system and 12–24 months—give suppliers leverage and raise vendor-lock risks.\u003c\/p\u003e\n\u003cp\u003eReliable partners are essential to meet HIPAA, GDPR and NIST requirements; breaches cost healthcare a mean $10.1M per incident in 2023, so security capability drives supplier bargaining power.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eGlobal health IT spend ≈ $250B (2024)\u003c\/li\u003e\n\u003cli\u003eHospital migration cost $5M–$50M\u003c\/li\u003e\n\u003cli\u003eMigration 12–24 months\u003c\/li\u003e\n\u003cli\u003eAvg breach cost $10.1M (2023)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFacility and Estate Management\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eTotally plc relies heavily on leased clinical space, so landlord power matters: UK commercial rent index rose 6.8% in 2024, squeezing margins and raising operating costs.\u003c\/p\u003e\n\u003cp\u003eSpecialized medical fit-outs cost £450–700 per sqm (NHS benchmark 2023), limiting quick relocations and increasing capex needs.\u003c\/p\u003e\n\u003cp\u003eLong-term leases secure patient continuity but lock the firm into locations and reduce agility.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eRent inflation 6.8% (UK, 2024)\u003c\/li\u003e\n\u003cli\u003eFit-out £450–700\/sqm (NHS 2023)\u003c\/li\u003e\n\u003cli\u003eLong leases = continuity vs agility trade-off\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Suppliers-Box-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSupplier power squeezes Totally plc: staffing shortages, concentrated vendors and rising costs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eSuppliers hold strong leverage over Totally plc: clinical staff shortages (NHS vacancies 133,000 Sept 2025) and 35% rise in agency nursing (2021–24) drive labor costs; top 3 MRI\/robotics suppliers control ~68% (2024), while drug list-price inflation ~4.5% (2024) and £450–700\/sqm fit-out costs plus 6.8% rent inflation (UK, 2024) raise switching costs and compress margins.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNHS vacancies\u003c\/td\u003e\n\u003ctd\u003e133,000 (Sep 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAgency nursing rise\u003c\/td\u003e\n\u003ctd\u003e~35% (2021–24)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTop-3 suppliers\u003c\/td\u003e\n\u003ctd\u003e~68% market (MRI\/robotics, 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eDrug inflation\u003c\/td\u003e\n\u003ctd\u003e~4.5% (2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRent inflation\u003c\/td\u003e\n\u003ctd\u003e6.8% (UK, 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eFit-out cost\u003c\/td\u003e\n\u003ctd\u003e£450–700\/sqm (NHS 2023)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eComprehensive Five Forces assessment for Totally that quantifies competitive intensity, buyer\/supplier power, substitute threats, and entry barriers, highlighting disruptive risks and strategic levers to defend market share—delivered in an editable format for investor decks and internal strategy use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eInteractive Porter’s Five Forces one-sheet that quantifies competitive pressure, letting teams quickly pinpoint and mitigate strategic risks with customizable scores and a ready-to-use radar chart for presentations.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eC\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eustomers Bargaining Power\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNHS Monopsony Power\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eThe NHS is Totally’s dominant buyer: in 2024 about 70–80% of UK community healthcare spend routes through the NHS, giving it monopsony leverage in contracting.\u003c\/p\u003e\n\u003cp\u003eIntegrated Care Boards set price caps and quality targets; failing to meet them risks losing multi-year contracts that made up 82% of Totally’s 2023 revenue.\u003c\/p\u003e\n\u003cp\u003eConcentrated NHS buying power constrains Totally’s pricing freedom—price increases are capped by annual NHS budget settlements (0.4% real-terms change in 2024\/25).\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStringent Performance Metrics\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eContracts with public health bodies tie payments to KPIs like 18-week referral-to-treatment targets and 92% A\u0026amp;E 4-hour waits; in 2024 UK trusts faced £150m+ in penalties for missed targets, so failure risks fines or non-renewal of lucrative contracts. This bargaining power forces Totally to focus on efficiency and quality—Totally must meet targets or lose up to an estimated 10–20% of contract value, so operational metrics drive strategy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePatient Choice Initiatives\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePatient Choice Initiatives shift power to individuals in elective care: 48% of UK elective patients (2024 NHS report) now can pick providers, so Totally can win higher referral share but must spend—marketing budgets may need 3–6% of revenue (industry benchmark) to maintain visibility. A 0.5-point drop in satisfaction (Net Promoter Score) can cut volumes by ~8% within 12 months, moving business to private or public rivals, so reputation management is critical.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eBudgetary Constraints of ICBs\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe financial health of Integrated Care Boards (ICBs) drives outsourced volume: NHS England reported 42% of ICBs in 2024 had deficits, shrinking discretionary spend and lowering contract awards to private providers.\u003c\/p\u003e\n\u003cp\u003eWhen public funding tightens, buyers may in-source services or demand double-digit price cuts at tenders—NHS procurement saw average margin compression of 6–12% in 2023–24.\u003c\/p\u003e\n\u003cp\u003eRevenue for private providers thus tracks national fiscal policy and NHS settlements, creating volatility in cashflow and capacity planning.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003e42% of ICBs in deficit (NHS England 2024)\u003c\/li\u003e\n\u003cli\u003e6–12% average margin compression in procurement (2023–24)\u003c\/li\u003e\n\u003cli\u003eHigh sensitivity to annual NHS funding settlements\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTransparency in Tendering\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eThe public nature of healthcare procurement lets buyers compare costs and outcomes across providers, increasing transparency; in 2024 UK NHS tender data showed average price variance of 22% across shortlisted suppliers, making it easy to spot lower-cost options.\u003c\/p\u003e\n\u003cp\u003eThis competitive bidding limits Totally’s ability to sustain high margins, as procurement teams routinely award contracts to bids 10–15% below incumbents; margin compression is visible in sector-wide average gross margins falling from 28% (2019) to 20% (2023).\u003c\/p\u003e\n\u003cp\u003eBuyers demand clear value-for-money evidence—cost per patient, outcome metrics, and real-world evidence—so Totally faces constant pressure to justify pricing and demonstrate measurable savings or outcomes.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePublic tenders enable direct cost\/outcome comparisons\u003c\/li\u003e\n\u003cli\u003e2024 tender variance ~22%, making low bids easy to find\u003c\/li\u003e\n\u003cli\u003eContracts often awarded 10–15% below incumbents\u003c\/li\u003e\n\u003cli\u003eSector gross margins fell from 28% (2019) to 20% (2023)\u003c\/li\u003e\n\u003cli\u003eProcurement requires strong cost-per-outcome proof\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/5FORCES-Content-Customers-Cart-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eNHS monopsony squeezes Totally: margins compressed as ICB deficits force efficiency\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe NHS is Totally’s dominant monopsony buyer (70–80% community spend, 2024), constraining prices via ICB-set caps and KPI-linked contracts (82% of Totally’s 2023 revenue). Financial strain in ICBs (42% in deficit, 2024) and procurement-driven margin compression (6–12% tender pressure; sector gross margins 28%→20% 2019–23) force efficiency, outcomes evidence, and marketing to protect elective volumes.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNHS share of spend (2024)\u003c\/td\u003e\n\u003ctd\u003e70–80%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTotally revenue from multi‑year contracts (2023)\u003c\/td\u003e\n\u003ctd\u003e82%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eICBs in deficit (2024)\u003c\/td\u003e\n\u003ctd\u003e42%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eProcurement margin compression (2023–24)\u003c\/td\u003e\n\u003ctd\u003e6–12%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSector gross margin 2019→2023\u003c\/td\u003e\n\u003ctd\u003e28%→20%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003eFull Version Awaits\u003c\/span\u003e\u003cbr\u003eTotally Porter's Five Forces Analysis\u003c\/h2\u003e\n\u003cp\u003eThis preview shows the exact Totally Porter's Five Forces Analysis you'll receive immediately after purchase—no placeholders or mockups; it's fully formatted, professional, and ready to download and use the moment you buy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56746889576825,"sku":"totallyplc-five-forces-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/totallyplc-five-forces-analysis.png?v=1772192861","url":"https:\/\/growthsharematrix.com\/products\/totallyplc-five-forces-analysis","provider":"Growth Share Matrix","version":"1.0","type":"link"}